Carlos Cordón-Cardo | Sociedad | EL PAÍS
Bo Gao - Adjunct Assistant Professor - Hunter College | LinkedIn
Mount Sinai's Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration - BroadcastMed
Health Technology Explained | Philips
Carlos Cordon-Cardo, MD, PhD | System Wide Chairman of Pathology at the Icahn School of Medicine at Mount Sinai
Events - Englander Institute for Precision Medicine
Early Warning Score reduces incidence of serious events in general ward - Case study | Philips
Mount Sinai applies algorithms, AI to classify disease | Fierce Healthcare
Patient-centered care and technology: a powerful partnership | Philips
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Maturity Models: CIO's Guide to a Successful Enterprise Imaging Strategy - Blog | Philips
Events - Englander Institute for Precision Medicine
Mount Sinai Health System on Twitter: "Dr. Carlos Cordon-Cardo, Chair of the Department of Pathology at @MountSinaiNYC, will be speaking at the #AtlanticPulse Summit on Wednesday, July 15. RSVP to attend @AtlanticLIVE's
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
COVID-19 pandemic (2019-21) - PLOS Collections
Mount Sinai applies algorithms, AI to classify disease | Fierce Healthcare
Events - Englander Institute for Precision Medicine
MountSinai Pathology (@MountSinai_Path) / Twitter
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" /
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Hace dos siglos alguien de 40 años era una persona mayor, ahora con 70 es joven" | Salud | EL PAÍS
Carlos Cordón-Cardó | Sociedad | EL PAÍS
